Erratum: PEGylated Silk Nanoparticles for Anticancer Drug Delivery (Biomacromolecules (2015) 16:11 (3712-3722) DOI: 10.1021/acs.biomac.5b01003);PEGylated Silk Nanoparticles for Anticancer Drug Delivery

Biomacromolecules

Volumn 16, Issue 11, 2015, Pages 3712-3722

  Wongpinyochit, Thidarat ^a   Uhlmann, Petra ^b   Urquhart, Andrew J ^c   Seib, F Philipp ^a,b  

^a UNIVERSITY OF STRATHCLYDE   (United Kingdom)

^b LEIBNIZ INSTITUTE OF POLYMER RESEARCH DRESDEN   (Germany)

^c TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ENCAPSULATION; MEDICAL NANOTECHNOLOGY; NANOPARTICLES; POLYETHYLENE GLYCOLS; POLYETHYLENE OXIDES; POLYETHYLENES; SILK; TARGETED DRUG DELIVERY;

ANTI-CANCER DRUG DELIVERY; AQUEOUS STABILITY; ENCAPSULATION EFFICIENCY; HUMAN BREAST CANCER CELLS; NANO PRECIPITATIONS; PH-DEPENDENT RELEASE; RELEASE BEHAVIORS; SURFACE GRAFTED;

CONTROLLED DRUG DELIVERY;

DOXORUBICIN; MACROGOL; NANOPARTICLE; PROPRANOLOL; SILK; SILK NANOPARTICLE; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; MACROGOL DERIVATIVE;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; AQUEOUS SOLUTION; ARTICLE; BOMBYX MORI; CANCER THERAPY; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG STABILITY; HUMAN; HUMAN CELL; MCF 7 CELL LINE; MOUSE; NANOENCAPSULATION; NANOFABRICATION; NONHUMAN; PH; PRECIPITATION; PRIORITY JOURNAL; SURFACE PROPERTY; ZETA POTENTIAL; ANIMAL; BOMBYX; CHEMISTRY; DRUG RELEASE; INFRARED SPECTROSCOPY; NANOMEDICINE; PARTICLE SIZE;

ANIMALS; ANTINEOPLASTIC AGENTS; BOMBYX; DRUG DELIVERY SYSTEMS; DRUG LIBERATION; HUMANS; HYDROGEN-ION CONCENTRATION; MCF-7 CELLS; NANOMEDICINE; NANOPARTICLES; PARTICLE SIZE; POLYETHYLENE GLYCOLS; SILK; SPECTROSCOPY, FOURIER TRANSFORM INFRARED;

EID: 84946750164     PISSN: 15257797     EISSN: 15264602     Source Type: Journal    
DOI: 10.1021/acs.biomac.6b00068     Document Type: Erratum

References (65)

1. Duncan, R.; Gaspar, R. Mol. Pharmaceutics 2011, 8, 2101-2141 10.1021/mp200394t
2. Duncan, R.; Vicent, M. J. Adv. Drug Delivery Rev. 2013, 65, 60-70 10.1016/j.addr.2012.08.012
3. Yin, H.; Kanasty, R. L.; Eltoukhy, A. A.; Vegas, A. J.; Dorkin, J. R.; Anderson, D. G. Nat. Rev. Genet. 2014, 15, 541-555 10.1038/nrg3763
4. Sheridan, C. Nat. Biotechnol. 2012, 30, 471-473 10.1038/nbt0612-471
5. Veiseh, O.; Tang, B. C.; Whitehead, K. A.; Anderson, D. G.; Langer, R. Nat. Rev. Drug Discovery 2014, 14, 45-57 10.1038/nrd4477
6. Hrkach, J.; Von Hoff, D.; Mukkaram Ali, M.; Andrianova, E.; Auer, J.; Campbell, T.; De Witt, D.; Figa, M.; Figueiredo, M.; Horhota, A.; Low, S.; McDonnell, K.; Peeke, E.; Retnarajan, B.; Sabnis, A.; Schnipper, E.; Song, J. J.; Song, Y. H.; Summa, J.; Tompsett, D.; Troiano, G.; Van Geen Hoven, T.; Wright, J.; LoRusso, P.; Kantoff, P. W.; Bander, N. H.; Sweeney, C.; Farokhzad, O. C.; Langer, R.; Zale, S. Sci. Transl. Med. 2012, 4, 128ra139 10.1126/scitranslmed.3003651
7. Fang, J.; Nakamura, H.; Maeda, H. Adv. Drug Delivery Rev. 2011, 63, 136-151 10.1016/j.addr.2010.04.009
8. Maeda, H.; Nakamura, H.; Fang, J. Adv. Drug Delivery Rev. 2013, 65, 71-79 10.1016/j.addr.2012.10.002
9. Matsumura, Y.; Maeda, H. Cancer Res. 1986, 46, 6387-6392
10. Torchilin, V. Adv. Drug Delivery Rev. 2011, 63, 131-135 10.1016/j.addr.2010.03.011
11. Duncan, R. Nat. Rev. Cancer 2006, 6, 688-701 10.1038/nrc1958
12. Seib, F. P.; Jones, A. T.; Duncan, R. J. Drug Target. 2006, 14, 375-390 10.1080/10611860600833955
13. Seib, F. P.; Jones, A. T.; Duncan, R. J. Controlled Release 2007, 117, 291-300 10.1016/j.jconrel.2006.10.020
14. Duncan, R.; Richardson, S. C. Mol. Pharmaceutics 2012, 9, 2380-2402 10.1021/mp300293n
15. de Duve, C.; de Barsy, T.; Poole, B.; Trouet, A.; Tulkens, P.; Van Hoof, F. Biochem. Pharmacol. 1974, 23, 2495-2531 10.1016/0006-2952(74)90174-9
16. Owens, D. E., 3rd; Peppas, N. A. Int. J. Pharm. 2006, 307, 93-102 10.1016/j.ijpharm.2005.10.010
17. Pasut, G.; Veronese, F. M. J. Controlled Release 2012, 161, 461-472 10.1016/j.jconrel.2011.10.037
18. Rabanel, J. M.; Hildgen, P.; Banquy, X. J. Controlled Release 2014, 185, 71-87 10.1016/j.jconrel.2014.04.017
19. Veronese, F. M.; Pasut, G. Drug Discovery Today 2005, 10, 1451-1458 10.1016/S1359-6446(05)03575-0
20. Bae, Y. H.; Park, K. J. Controlled Release 2011, 153, 198-205 10.1016/j.jconrel.2011.06.001
21. Spiess, K.; Lammel, A.; Scheibel, T. Macromol. Biosci. 2010, 10, 998-1007 10.1002/mabi.201000071
22. Werner, V.; Meinel, L. Eur. J. Pharm. Biopharm. 2015, 10.1016/j.ejpb.2015.03.016
23. Seib, F. P.; Kaplan, D. L. Isr. J. Chem. 2013, 53, 756-766 10.1002/ijch.201300083
24. Omenetto, F. G.; Kaplan, D. L. Science 2010, 329, 528-531 10.1126/science.1188936
25. Wenk, E.; Wandrey, A. J.; Merkle, H. P.; Meinel, L. J. Controlled Release 2008, 132, 26-34 10.1016/j.jconrel.2008.08.005
26. Wang, X.; Yucel, T.; Lu, Q.; Hu, X.; Kaplan, D. L. Biomaterials 2010, 31, 1025-1035 10.1016/j.biomaterials.2009.11.002
27. Xie, R.-J.; Wu, H.-Y.; Xu, J.-M.; Deng, Q.-M. J. Fiber Bioeng Info 2008, 1, 73-80 10.3993/jfbi06200810
28. Gupta, V.; Aseh, A.; Rios, C. N.; Aggarwal, B. B.; Mathur, A. B. Int. J. Nanomed. 2009, 4, 115-122 10.2147/IJN.S5581
29. Lammel, A. S.; Hu, X.; Park, S. H.; Kaplan, D. L.; Scheibel, T. R. Biomaterials 2010, 31, 4583-4591 10.1016/j.biomaterials.2010.02.024
30. Zhao, Z.; Li, Y.; Chen, A.-Z.; Zheng, Z.-J.; Hu, J.-Y.; Li, J.-S.; LI, G. Ind. Eng. Chem. Res. 2013, 52, 3752-3761 10.1021/ie301907f
31. Xie, M.-B.; Li, Y.; Zhao, Z.; Chen, A.-Z.; Li, J.-S.; Hu, J.-Y.; LI, G.; Li, Z. J. Supercrit. Fluids 2015, 103, 1-9 10.1016/j.supflu.2015.04.021
32. Kundu, J.; Chung, Y. I.; Kim, Y. H.; Tae, G.; Kundu, S. C. Int. J. Pharm. 2010, 388, 242-250 10.1016/j.ijpharm.2009.12.052
33. Seib, F. P.; Jones, G. T.; Rnjak-Kovacina, J.; Lin, Y.; Kaplan, D. L. Adv. Healthcare Mater. 2013, 2, 1606-1611 10.1002/adhm.201300034
34. Zhang, Y. Q.; Shen, W. D.; Xiang, R. L.; Zhuge, L. J.; Gao, W. J.; Wang, W. B. J. Nanopart. Res. 2007, 9, 885-900 10.1007/s11051-006-9162-x
35. Zhao, Z.; Li, Y.; Xie, M. B. Int. J. Mol. Sci. 2015, 16, 4880-4903 10.3390/ijms16034880
36. Borkner, C. B.; Elsner, M. B.; Scheibel, T. ACS Appl. Mater. Interfaces 2014, 6, 15611-15625 10.1021/am5008479
37. Heim, M.; Keerl, D.; Scheibel, T. Angew. Chem., Int. Ed. 2009, 48, 3584-3596 10.1002/anie.200803341
38. Price, R.; Poursaid, A.; Ghandehari, H. J. Controlled Release 2014, 190, 304-313 10.1016/j.jconrel.2014.06.016
39. Xia, X. X.; Wang, M.; Lin, Y.; Xu, Q.; Kaplan, D. L. Biomacromolecules 2014, 15, 908-914 10.1021/bm4017594
40. Numata, K.; Kaplan, D. L. Adv. Drug Delivery Rev. 2010, 62, 1497-1508 10.1016/j.addr.2010.03.009
41. Pritchard, E. M.; Dennis, P. B.; Omenetto, F.; Naik, R. R.; Kaplan, D. L. Biopolymers 2012, 97, 479-498 10.1002/bip.22026
42. Florczak, A.; Mackiewicz, A.; Dams-Kozlowska, H. Biomacromolecules 2014, 15, 2971-2981 10.1021/bm500591p
43. Rockwood, D. N.; Preda, R. C.; Yucel, T.; Wang, X.; Lovett, M. L.; Kaplan, D. L. Nat. Protoc. 2011, 6, 1612-1631 10.1038/nprot.2011.379
44. Vepari, C.; Matheson, D.; Drummy, L.; Naik, R.; Kaplan, D. L. J. Biomed. Mater. Res., Part A 2010, 93, 595-606 10.1002/jbm.a.32565
45. Mains, J.; Lamprou, D. A.; McIntosh, L.; Oswald, I. D.; Urquhart, A. J. Chem. Commun. 2013, 49, 5082-5084 10.1039/c3cc41583j
46. Hu, X.; Kaplan, D.; Cebe, P. Macromolecules 2006, 39, 6161-6170 10.1021/ma0610109
47. Seib, F. P.; Maitz, M. F.; Hu, X.; Werner, C.; Kaplan, D. L. Biomaterials 2012, 33, 1017-1023 10.1016/j.biomaterials.2011.10.063
48. Chou, T. C. Pharmacol. Rev. 2006, 58, 621-681 10.1124/pr.58.3.10
49. Seib, F. P.; Muller, K.; Franke, M.; Grimmer, M.; Bornhauser, M.; Werner, C. Tissue Eng., Part A 2009, 15, 3161-3171 10.1089/ten.tea.2008.0600
50. Cortes, J. E.; Goldberg, S. L.; Feldman, E. J.; Rizzeri, D. A.; Hogge, D. E.; Larson, M.; Pigneux, A.; Recher, C.; Schiller, G.; Warzocha, K.; Kantarjian, H.; Louie, A. C.; Kolitz, J. E. Cancer 2015, 121, 234-242 10.1002/cncr.28974
51. Pantziarka, P.; Bouche, G.; Meheus, L.; Sukhatme, V.; Sukhatme, V. P. Future Oncol. 2015, 11, 181-184 10.2217/fon.14.244
52. Ji, Y.; Chen, S.; Xiao, X.; Zheng, S.; Li, K. OncoTargets Ther. 2012, 5, 391-401 10.2147/OTT.S38403
53. Webster, R.; Didier, E.; Harris, P.; Siegel, N.; Stadler, J.; Tilbury, L.; Smith, D. Drug Metab. Dispos. 2006, 35, 9-16 10.1124/dmd.106.012419
54. Greenwald, R. B.; Choe, Y. H.; McGuire, J.; Conover, C. D. Adv. Drug Delivery Rev. 2003, 55, 217-250 10.1016/S0169-409X(02)00180-1
55. Thierry, B.; Griesser, H. J. J. Mater. Chem. 2012, 22, 8810-8819 10.1039/c2jm30210a
56. Stolnik, S.; Dunn, S. E.; Garnett, M. C.; Davies, M. C.; Coombes, A. G. A.; Taylor, D. C.; Irving, M. P.; Purkiss, S. C.; Tadros, T. F.; Davis, S. S.; Illum, L. Pharm. Res. 1994, 11, 1800-1808 10.1023/A:1018931820564
57. Murphy, A. R.; Kaplan, D. L. J. Mater. Chem. 2009, 19, 6443-6450 10.1039/b905802h
58. Bancos, S.; Stevens, D. L.; Tyner, K. M. Int. J. Nanomed. 2014, 10, 183-206 10.2147/IJN.S72580
59. Pondman, K. M.; Sobik, M.; Nayak, A.; Tsolaki, A. G.; Jakel, A.; Flahaut, E.; Hampel, S.; Ten Haken, B.; Sim, R. B.; Kishore, U. Nanomedicine 2014, 10, 1287-1299 10.1016/j.nano.2014.02.010
60. Thomas, V.; Halloran, B. A.; Ambalavanan, N.; Catledge, S. A.; Vohra, Y. K. Acta Biomater. 2012, 8, 1939-1947 10.1016/j.actbio.2012.01.033
61. Lammel, A.; Schwab, M.; Hofer, M.; Winter, G.; Scheibel, T. Biomaterials 2011, 32, 2233-2240 10.1016/j.biomaterials.2010.11.060
62. Fontana, G.; Licciardi, M.; Mansueto, S.; Schillaci, D.; Giammona, G. Biomaterials 2001, 22, 2857-2865 10.1016/S0142-9612(01)00030-8
63. Pasquier, E.; Ciccolini, J.; Carre, M.; Giacometti, S.; Fanciullino, R.; Pouchy, C.; Montero, M. P.; Serdjebi, C.; Kavallaris, M.; Andre, N. Oncotarget 2011, 2, 797-809 10.18632/oncotarget.343
64. Holliday, D. L.; Speirs, V. Breast Cancer Res. 2011, 13, 215 10.1186/bcr2889
65. Wang, T.; Upponi, J. R.; Torchilin, V. P. Int. J. Pharm. 2012, 427, 3-20 10.1016/j.ijpharm.2011.07.013